GlassScriptPhysician profile
Sarah Morrison
NPI 1124736897
$1,212.16
in general payments reported to CMS, 2019-2025
21 companies · $352 in 2025
The $352 reported for 2025 was more than what a typical Family provider received nationally (typical 2025 total: $167).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $45.79 · 2023: $453 · 2024: $361 · 2025: $352.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,166.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,166.37 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astrazeneca Pharmaceuticals LP | $234.67 | 2023-2024 | Farxiga, Airsupra, Breztri |
| Bayer Healthcare Pharmaceuticals INC. | $143.81 | 2022-2025 | |
| Novo Nordisk INC | $104.42 | 2023-2025 | Rybelsus, Ozempic, Wegovy |
| Abbvie INC. | $84.57 | 2023-2025 | |
| Biogen, INC. | $84.47 | 2024-2025 | Zurzuvae |
| Otsuka America Pharmaceutical, INC. | $74.36 | 2023-2024 | Rexulti, Abilify Maintena |
| Exeltis, USA INC. | $63.45 | 2024-2025 | Slynd |
| Sumitomo Pharma America, INC. | $54.34 | 2024-2025 | Myfembree |
| Hologic Sales and Service, LLC | $53.23 | 2025 | Novasure, Aptima |
| Amgen INC. | $51.72 | 2023 | Otezla, Repatha |
| Organon LLC | $47.36 | 2024-2025 | Nexplanon |
| Mylan Specialty L.P. | $46.48 | 2023-2024 | Yupelri |
| Lilly USA, LLC | $30.28 | 2023-2024 | Mounjaro, Zepbound |
| Organogenesis INC. | $28.41 | 2025 | Puraply Wound Matrix |
| Sanofi Pasteur INC. | $19.72 | 2024 |
Show all 21 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Shield Therapeutics INC | $18.00 | 2025 | |
| Vertex Pharmaceuticals Incorporated | $16.29 | 2025 | |
| Exact Sciences Corporation | $15.52 | 2025 | Cologuard Collection Kit |
| Novartis Pharmaceuticals Corporation | $14.33 | 2023 | |
| Mayne Pharma Commercial LLC | $14.33 | 2025 | |
| Kowa Pharmaceuticals America, INC. | $12.40 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Sarah Morrison listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.